READOUT / 05 — FREQUENT QUESTIONS
TB-500 FAQ: what the studies answer, and what they leave open.
Direct answers, cited where they carry a number, with the fragment-versus-parent caveat kept in view.
Identity and definitions
Plain answers to the TB-500 questions readers ask most, drawn only from the cited record. Where an answer carries a figure, the figure maps to a numbered study on the references and citations page.
What is TB-500 used for in research?
In the literature, thymosin beta-4 and the LKKTETQ region carried by TB-500 are studied for tissue repair and wound healing, cell migration, angiogenesis, anti-inflammatory and anti-fibrotic effects, and cardiac, corneal, and neurological injury models — predominantly in animals and in vitro [10]. The fragment's human efficacy is not established [1].
What is TB-500?
TB-500 is the synthetic, N-acetylated heptapeptide Ac-LKKTETQ — residues 17 to 23 (the actin-binding motif) of the 43-amino-acid protein thymosin beta-4. It is sold for research and veterinary use; most published efficacy data are on the full-length protein, not the seven-mer [1].
What does TB-500 stand for and what does TB stand for in TB-500?
TB references thymosin beta (thymosin beta-4); TB-500 is the research and veterinary designation for the synthetic Ac-LKKTETQ fragment of that protein, not an abbreviation with an official chemical expansion beyond its thymosin-beta-4 origin [1].
Is TB-500 a Steroid?
No. TB-500 is a synthetic peptide fragment of thymosin beta-4 — the Ac-LKKTETQ heptapeptide — not a steroid. Steroids share a four-ring lipid scaffold and act largely through nuclear hormone receptors; TB-500 is a short chain of seven amino acids whose described activity centers on actin binding and cell migration [1][2].
Efficacy questions
These answers describe what was measured, in which model. Animal and in-vitro findings are flagged as such; none establishes efficacy of the seven-mer in humans.
Does TB-500 work for muscle tears and recovery from exercise?
Animal data show thymosin beta-4 acts as a myoblast chemoattractant and increased regenerating fibers in dystrophin-deficient (mdx) mice — but that same study found no gain in muscle strength [1]. A 2026 Sports Medicine review lists TB-500 among unapproved peptides with favorable animal outcomes but scarce human safety and efficacy data [17].
Can TB-500 help with tendon injuries and ligament repair?
Thymosin beta-4 enhanced healing of medial collateral ligament injury in a rat model — one of the few direct connective-tissue findings underpinning the athletic-recovery rationale [1]. Human tendon and ligament efficacy for the fragment is unproven [1].
Does TB-500 increase hair growth?
Full-length thymosin beta-4 has been reported to activate hair-follicle bulge stem cells and promote hair growth in rodents [1]. This is a parent-protein animal finding; there is no controlled human evidence that the TB-500 fragment increases hair growth [1].
What is the difference between TB-500 and BPC-157?
They are unrelated peptides studied for tissue repair. TB-500 is the Ac-LKKTETQ actin-binding fragment of thymosin beta-4; BPC-157 is a separate gastric-derived peptide. A 2026 Sports Medicine review lists both among unapproved peptides with scarce human safety data [17].
Safety questions
Safety is where the honest gaps are widest. The fragment has no controlled human safety profile; the most-cited concern is mechanistic.
Does TB-500 cause cancer or promote tumor growth?
Thymosin beta-4 is overexpressed in several cancers and implicated in metastasis and tumor angiogenesis, so its pro-migratory and pro-angiogenic activity is a recognized theoretical oncologic concern [1][8]. This is a safety signal, not a demonstrated outcome of the fragment in humans; human safety data are limited [1].
What are the side effects of TB-500?
No controlled human side-effect profile is established for the fragment. Intravenous full-length thymosin beta-4 was well tolerated to 1260 mg in a Phase 1 study [5], but the chief documented concerns are the theoretical tumor-angiogenesis risk [1][8] and unreliable research-grade purity — which is exactly why sourcing due-diligence (identity, third-party COAs) matters [1].
Is TB-500 safe for long-term use?
Long-term human safety of the TB-500 fragment is unknown — there are no completed controlled long-term human trials [1]. The tumor-angiogenesis signal [1][8] and unregulated material quality are the key open concerns; this is a research compound, not a human therapy [1].
Is TB-500 banned by WADA and in competitive sports?
Yes. TB-500 and thymosin beta-4 fall under WADA prohibited peptide, growth-factor, and tissue-repair categories, banned in and out of competition for the relevant classes, and are detectable by LC-MS anti-doping assays in equine and human matrices [1]. The TB-500 legal status and FDA 503A category page covers the regulatory standing in full.